SCHEMBL11295162

SCHEMBL11295162

O=C1c2ccccc2C(=O)N1C(Cc1ccccc1)P(=O)(O)O

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
GAA P10253 1/20 0.58
TDP1 Q9NUW8 1/20 0.57
POLB P06746 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
LAP3 P28838 3/20 0.49
ANPEP P15144 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
PKM P14618 1/20 0.48
ACP3 P15309 1/20 0.47
AADAT Q8N5Z0 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
HSD11B1 P28845 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327258 0.81 ALDH1A1 (0.55) ALDH1A1GAATDP1POLBL3MBTL1
SCHEMBL11177177 0.78 TDP1 (0.54) ALDH1A1GAATDP1POLBL3MBTL1
SCHEMBL11169560 0.77 TDP1 (0.52) ALDH1A1GAATDP1POLBL3MBTL1
SCHEMBL8928325 0.75 LAP3 (0.53) LAP3ANPEPACP3LMNATSHR
SCHEMBL3444977 0.73 ALDH1A1 (0.61) ALDH1A1GAATDP1POLBL3MBTL1
SCHEMBL478614 0.73 ALDH1A1 (1.00) ALDH1A1GAAPOLBL3MBTL1SMN1; SMN2
SCHEMBL4861809 0.73 ALDH1A1 (1.00) ALDH1A1GAAPOLBL3MBTL1SMN1; SMN2
SCHEMBL1237351 0.73 ALDH1A1 (0.61) ALDH1A1GAATDP1POLBL3MBTL1
SCHEMBL392680 0.73 ALDH1A1 (1.00) ALDH1A1GAAPOLBL3MBTL1SMN1; SMN2
SCHEMBL30216480 0.73 ALDH1A1 (1.00) ALDH1A1GAAPOLBL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0058427-A2 Substituted phosphonamides, a process for preparing the same and a pharmaceutical composition which is useful in the treatment of hypertension MERCK & CO. INC. (US) 1982-08-25 EP disclosed